Utah launches first in nation pilot for autonomous artificial intelligence prescription renewals
Utah has launched a 12 month pilot program that allows an artificial intelligence system to autonomously renew prescriptions for certain patients with stable chronic conditions. The initiative focuses on nearly 200 commonly used medications for diseases such as diabetes and hypertension. These are conditions where missed refills can quickly lead to complications and increased healthcare utilization. The program begins with an initial phase of 250 physician reviewed cases to ensure safety. After that period, the system is expected to begin making renewal decisions independently within the state’s regulatory sandbox. According to the Utah Department of Commerce release, this represents the first state approved program of its kind in the United States. That makes it a critical early test of how artificial intelligence might be integrated into routine clinical decision making. The appeal is clear, as refill management is repetitive, time consuming, and often poorly matched to clinician time. At the same time, the program raises significant questions about oversight and accountability. The World Health Organization report on artificial intelligence in health highlights the importance of transparency, safety, and human control in these systems. Legal concerns are also substantial. The University of Illinois law analysis explores whether systems like this should be regulated differently or require additional approval pathways. These questions will likely shape how similar programs are deployed in other states. If the pilot proves safe, it could expand into other areas of routine care. If not, it may slow the pace of autonomous clinical decision making. Either way, this program marks an important shift from artificial intelligence as a support tool to artificial intelligence as an active participant in care delivery.
Image: PD
©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.